315 related articles for article (PubMed ID: 31002892)
1. NF-κB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-κB/Snail signaling in bladder cancer cells.
Zhang Q; Mao Z; Sun J
Gene; 2019 Aug; 710():91-97. PubMed ID: 31002892
[TBL] [Abstract][Full Text] [Related]
2. Snail-overexpressing Cancer Cells Promote M2-Like Polarization of Tumor-Associated Macrophages by Delivering MiR-21-Abundant Exosomes.
Hsieh CH; Tai SK; Yang MH
Neoplasia; 2018 Aug; 20(8):775-788. PubMed ID: 29981499
[TBL] [Abstract][Full Text] [Related]
3. MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail.
Fan MJ; Zhong YH; Shen W; Yuan KF; Zhao GH; Zhang Y; Wang SK
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2642-2649. PubMed ID: 28678320
[TBL] [Abstract][Full Text] [Related]
4. Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages.
Wu ATH; Srivastava P; Yadav VK; Tzeng DTW; Iamsaard S; Su EC; Hsiao M; Liu MC
Toxicol Appl Pharmacol; 2020 Aug; 401():115109. PubMed ID: 32544403
[TBL] [Abstract][Full Text] [Related]
5. Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit.
Mak KK; Wu AT; Lee WH; Chang TC; Chiou JF; Wang LS; Wu CH; Huang CY; Shieh YS; Chao TY; Ho CT; Yen GC; Yeh CT
Mol Nutr Food Res; 2013 Jul; 57(7):1123-34. PubMed ID: 23504987
[TBL] [Abstract][Full Text] [Related]
6. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
[TBL] [Abstract][Full Text] [Related]
8. MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.
Xu M; Li J; Wang X; Meng S; Shen J; Wang S; Xu X; Xie B; Liu B; Xie L
Cell Death Dis; 2018 Feb; 9(2):209. PubMed ID: 29434190
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
11. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.
Liu CY; Xu JY; Shi XY; Huang W; Ruan TY; Xie P; Ding JL
Lab Invest; 2013 Jul; 93(7):844-54. PubMed ID: 23752129
[TBL] [Abstract][Full Text] [Related]
12. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.
Yang C; Dou R; Wei C; Liu K; Shi D; Zhang C; Liu Q; Wang S; Xiong B
Mol Ther; 2021 Jun; 29(6):2088-2107. PubMed ID: 33571679
[TBL] [Abstract][Full Text] [Related]
14. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
15. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling.
Zhu Z; Wang H; Qian X; Xue M; Sun A; Yin Y; Tang J; Zhang J
Clin Breast Cancer; 2024 Jun; 24(4):e244-e257.e1. PubMed ID: 38378361
[TBL] [Abstract][Full Text] [Related]
16. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
17. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor α induces epithelial-mesenchymal transition and promotes metastasis via NF-κB signaling pathway-mediated TWIST expression in hypopharyngeal cancer.
Yu L; Mu Y; Sa N; Wang H; Xu W
Oncol Rep; 2014 Jan; 31(1):321-7. PubMed ID: 24220622
[TBL] [Abstract][Full Text] [Related]
19. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
20. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]